CAS登錄號 | 中文名 | 英文名 | 分子結(jié)構(gòu)式 | 分子式 | 詳情 | 供應商 |
16944-60-8 | (S)-3-異丙基-2,5-哌嗪二酮 | (S)-3-Isopropyl-2,5-piperazinedione; 2,5-Piperazinedione,3-(1-methylethyl)-, (S)-; 2,5-Piperazinedione, 3-isopropyl-, L- (8CI); Cyclic glycylvaline; Cyclic(glycylvalyl); Cyclo(L-valylglycine); Cyclo(glycyl-L-valyl); Cyclo-Gly-L-Val; Cycloglycyl-L-valine; L-Valylglycine diketopiperazine | ![]() | C7H12N2O2 | 詳情 | 供應商 |
24584-09-6 | 右雷佐生; 右丙亞胺; :(S)-4,4'-(1-甲基-1,2-乙二基)雙-2,6-哌嗪二酮 | Dexrazoxane; (S)-4,4'-(1-Methyl-1,2-ethanediyl)bis-2,6-piperazinedione | ![]() | C11H16N4O4 | 詳情 | 供應商 |
106-57-0 | 甘氨酸酐; 2,5-哌嗪二酮 | 2,5-diketopiperazine; 2,5-dioxopiperazine; 2,5-piperazinedione; alpha,gamma-diacipiperazine; cyclo(glycylglycyl); cyclodiglycine; cycloglycylglycine | ![]() | C4H6N2O2 | 詳情 | 供應商 |
21416-67-1 | 丙亞胺; 丙二胺亞胺; 丙乙胺亞胺; 雙哌嗪二酮丙烷; 丙二胺四乙酰亞胺; 抗癌散; 寧癌-159; 亞胺-159; 抗癌-173; 抗癌1 | 2,6-Piperazinedione,4,4'-(1-methyl-1,2-ethanediyl)bis-; 2,6-Piperazinedione,4,4'-propylenedi- (8CI); (?à)-1,2-Bis(3,5-dioxopiperazin-1-yl)propane; 1,2-Bis(3,5-dioxo-1-piperazinyl)propane; 4,4'-Propylenebis(2,6-piperazinedione); 4,4'-Propylenedi(2,6-piperazinedione); ICI 59118; ICRF 159; NSC 129943; Razoxane; Razoxin; Tepirone; Troxozone; 83713-23-9; | ![]() | C11H16N4O4 | 詳情 | 供應商 |
5436-01-1 | 1-甲基-3,6-(1H,2H)哌嗪二酮; 1-甲基-3,6-吡嗪二酮; 1-甲基-3,6-(1H,2H)哌嗪二酮 | 3,6-Pyridazinedione,1,2-dihydro-1-methyl-; 3(2H)-Pyridazinone,6-hydroxy-2-methyl- (6CI); 1-Methyl-1,2-dihydro-3,6-pyridazinedione; 1-Methyl-3,6-pyridazinedione; 6-Hydroxy-2-methyl-3(2H)-pyridazinone; N-Methyl-3,6-pyridazinedione; N-Methylmaleic hydrazide; NSC 21412 | ![]() | C5H6N2O2 | 詳情 | 供應商 |